Effect of Zofenopril on regeneration of sciatic nerve crush injury in a rat model

被引:30
作者
Kalender, Ali Murat [1 ]
Dogan, Ali [2 ]
Bakan, Vedat [3 ]
Yildiz, Huseyin [4 ]
Gokalp, Mehmet Ata [2 ]
Kalender, Mahmut [5 ]
机构
[1] Kahramanmaras Sutcu Imam Univ, Fac Med, Dept Orthoped & Traumatol, Kahramanmaras, Turkey
[2] Yuzuncu Yil Univ, Fac Med, Dept Orthoped & Traumatol, Van, Turkey
[3] Kahramanmaras Sutcu Imam Univ, Fac Med, Dept Pediat Surg, Kahramanmaras, Turkey
[4] Kahramanmaras Sutcu Imam Univ, Fac Med, Dept Anesthesiol & Reanimat, Kahramanmaras, Turkey
[5] Gaziantep Med Ctr, Gaziantep, Turkey
关键词
D O I
10.1186/1749-7221-4-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Zofenopril is an antioxidant agent which has been shown to have beneficial effects in hypertension and heart failure. The aim of this study was to test the effects of Zofenopril on nerve regeneration and scarring in a rat model of peripheral nerve crush injury. Methods: Twenty-one adult Sprague-Dawley rats underwent a surgical procedure involving right sciatic nerve crush injury. 15 mg/kg Zofenopril was administered orally to seven rats in group Z for seven days. Seven rats in group S received saline orally for seven days. Seven rats in the control group C received no drug after crush injury. Fourteenth and 42nd days after injury, functional and electromyography assessments of nerves were performed. Functional recovery was analyzed using a walking track assessment, and quantified using the sciatic functional index (SFI). After these evaluations, all rats were sacrificed and microscopic evaluations were performed. Results: The Sciatic functional Index (SFI) in group Z on 14th day is different significantly from group S and group C (p = 0.037). But on 42nd day there was no difference between groups (p = 0.278). The statistical analyses of electromyelographic (EMG) studies showed that the latency in group Z is significantly different from group S (p = 0.006) and group C (p = 0.045). But on 42nd day there was no difference between groups like SFI (p = 0.147). The amplitude was evaluated better in group Z than others (p < 0.05). In microscopic evaluation, we observed the highest number of nerve regeneration in the group Z and the lowest in the group C. But it was not significant statistically. Conclusion: Our results demonstrate that Zofenopril promotes the regeneration of peripheral nerve injuries in rat models.
引用
收藏
页数:7
相关论文
共 32 条
[1]   Systemic betamethasone accelerates functional recovery after a crush injury to rat sciatic nerve [J].
Al-Bishri, A ;
Dahlin, L ;
Sunzel, B ;
Rosenquist, J .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2005, 63 (07) :973-977
[2]  
Altunoluk B, 2006, ANN CLIN LAB SCI, V36, P326
[3]   The effects of carnitine on distally-burned dorsal skin flap:: an experimental study in rats [J].
Arslan, E ;
Milcan, A ;
Ünal, S ;
Demirkan, F ;
Polat, A ;
Bagdatoglu, Ö ;
Aksoy, A ;
Polat, G .
BURNS, 2003, 29 (03) :221-227
[4]   Effect of trapidil in ischemia/reperfusion injury of peripheral nerves [J].
Bagdatoglu, C ;
Saray, A ;
Surucu, HS ;
Ozturk, H ;
Tamer, L .
NEUROSURGERY, 2002, 51 (01) :212-219
[5]   FUNCTIONAL-EVALUATION OF COMPLETE SCIATIC, PERONEAL, AND POSTERIOR TIBIAL NERVE LESIONS IN THE RAT [J].
BAIN, JR ;
MACKINNON, SE ;
HUNTER, DA .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1989, 83 (01) :129-136
[6]   Zofenopril - A review of the evidence of its benefits in hypertension and acute myocardial infarction [J].
Borghi, C ;
Ambrosioni, E .
CLINICAL DRUG INVESTIGATION, 2000, 20 (05) :371-384
[7]   NERVE CRUSH INJURIES - A MODEL FOR AXONOTMESIS [J].
BRIDGE, PM ;
BALL, DJ ;
MACKINNON, SE ;
NAKAO, Y ;
BRANDT, K ;
HUNTER, DA ;
HERTL, C .
EXPERIMENTAL NEUROLOGY, 1994, 127 (02) :284-290
[8]   Angiotensin-converting enzyme inhibitors [J].
Brown, NJ ;
Vaughan, DE .
CIRCULATION, 1998, 97 (14) :1411-1420
[9]   ANTIOXIDANT EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS - FREE-RADICAL AND OXIDANT SCAVENGING ARE SULFHYDRYL DEPENDENT, BUT LIPID-PEROXIDATION IS INHIBITED BY BOTH SULFHYDRYL-CONTAINING AND NONSULFHYDRYL-CONTAINING ACE INHIBITORS [J].
CHOPRA, M ;
BESWICK, H ;
CLAPPERTON, M ;
DARGIE, HJ ;
SMITH, WE ;
MCMURRAY, J .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 19 (03) :330-340
[10]  
Cushman DW, 1992, PHARM RES, V9, P1480